Sarah Jane Tribble, Kaiser Health News

Sarah Jane Tribble

Kaiser Health News

Washington, DC, United States

Contact Sarah

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • Kaiser Health News
Past:
  • CaliforniaHealthline
  • Truthout
  • NPR
  • KMUW
  • WGBH
  • STAT

Recent articles by Sarah:

Buy and Bust: After Platinum Health Took Control of Noble Sites, All Hospital Workers Were Fired

Two Missouri towns are without operating hospitals after private equity-backed Noble Health left both facilities mired in debt, lawsuits, and federal investigations. The hospitals’ new operator, Pl… → Read More

Buy and Bust: Collapse of Private Equity-Backed Rural Hospitals Mired Employees in Medical Bills

The U.S. Labor Department investigates Noble Health after former employees of its shuttered Missouri hospitals say the private equity-backed owner took money from their paychecks and then failed to… → Read More

Rural Hospital Rescue Program Is Met With Skepticism From Administrators

A new federal rescue program that pays rural hospitals to shutter underused inpatient units and focus solely on emergency rooms and outpatient care hasn’t generated much interest yet. → Read More

Buy and Bust: When Private Equity Comes for Rural Hospitals

Noble Health swept into two small Missouri towns promising to save their hospitals. Instead, workers and vendors say it stopped paying bills and government inspectors found it put patients at risk.… → Read More

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

After years of failure, the Maryland company aims to attract the vaccine-hesitant with an alternative to mRNA shots. But will it find a market? → Read More

As Big Pharma and Hospitals Battle Over Drug Discounts, Patients Miss Out on Millions in Benefits

The number of pharmacies dispensing 340B discounted drugs soared to more than 31,000 this year. Drugmakers struck back by halting some discounts. Hospitals say they are losing millions of dollars —… → Read More

‘No Mercy’ Bonus Episodes: More From Fort Scott, Kansas

Check out the latest bonus episodes from the award-winning “Where It Hurts” podcast. → Read More

What the Stalemate on Capitol Hill Means for Your Drug Prices

Despite big 2020 campaign promises to deliver lower costs on prescription drugs, Democrats have failed to unite around a legislative plan. → Read More

How Fauci and the NIH Got Ahead of the FDA and CDC in Backing Boosters

With real-time data streaming in from highly specialized researchers in the U.S. and abroad, NIH scientists became convinced that boosting the covid-19 vaccine was needed to save lives, prompting t… → Read More

The White House Says Boosters for All. Here’s What You Need to Know.

Federal officials are preparing to offer those who received Pfizer or Moderna covid vaccines a third dose in September. But the FDA and CDC are still reviewing the data for final clearance. → Read More

Rush to Boosters Sparks Confusion, Differing Recommendations

With political pressure mounting to recommend boosters, what are the experts saying about how current vaccines work and the potential benefits of another dose? → Read More

The White House Says Boosters for All. Here’s What You Need to Know.

Federal officials are preparing to offer those who received Pfizer or Moderna covid vaccines a third dose in September. But the FDA and CDC are still reviewing the data for final clearance. → Read More

Pfizer CEO to Public: Just Trust Us on the Covid Booster

As pharmaceutical companies declare a need for boosters, scientists and doctors emphasize there’s no proof yet. → Read More

Pfizer CEO to Public: Just Trust Us on the Covid Booster

As pharmaceutical companies declare a need for boosters, scientists and doctors emphasize there’s no proof yet. → Read More

Health Experts Say Expanding Vaccine Access Requires More Than Patent Waivers

In the best-case scenario, sharing patents is only a tiny step in the vastly complex work of making a COVID vaccine. → Read More

This Small Canadian Drugmaker Wants to Make J&J Vaccines for Poor Nations. It Needs More Than a Patent Waiver.

All agree that covid vaccines are urgently needed to stop the pandemic, but simply waiving patents fails to provide technological know-how and address supply chain challenges. → Read More

‘It Didn’t Really Stick With Me’: Understanding the Rural Shrug Over Covid and Vaccines

Fort Scott, Kansas, was hit hard by the pandemic, and it no longer has a hospital. But residents remain skeptical about the impact of the coronavirus. → Read More

Pfizer’s Newest Vaccine Plant Has Persistent Mold Issues, History of Recalls

After nearly a decade’s worth of federal inspections, reprimands and corrective action plans, has Pfizer fixed the facility that will be filling vials of its covid vaccine? → Read More

Why AstraZeneca and J&J’s Vaccines, In Use the World Over, Are Still on Hold in America

Covid has pressed the Food and Drug Administration into its fastest vaccine reviews ever — which are still painfully slow, critics say. → Read More

Remdesivir, Given to Half of Hospitalized Covid Patients in U.S., Is Big Win for Gilead — Boosted by Taxpayers

With U.S. cases skyrocketing, demand for Gilead’s dark horse antiviral is only growing. Biden appointees propose potential legal tactics to tamp down the price for patients. → Read More